Skip to main content
logo
Dr. Reddy's Laboratories Limited (BOM:500124)
India flag India · Delayed Price · Currency is INR
1,224.50
-14.50 (-1.17%)
At close: Oct 23, 2026

Dr. Reddy's Laboratories Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
27,98642,85056,54455,68445,06723,568
Depreciation & Amortization
21,43020,60517,05814,84112,63611,824
Loss (Gain) From Sale of Assets
-2,684-2,547-1,522-900208-1,119
Asset Writedown & Restructuring Costs
2,9953,5191,69336997,562
Loss (Gain) From Sale of Investments
-2,291-2,359-3,554-3,149-876-277
Loss (Gain) on Equity Investments
--134-217-147-370-703
Stock-Based Compensation
310326424407397592
Provision & Write-off of Bad Debts
35169016127520555
Other Operating Activities
5,6765,4415,830-1,3998,7645,104
Change in Accounts Receivable
1,144-6,722-10,283-8,054-5,752-17,012
Change in Inventory
-10,689-8,601-12,753-18,445-2,654-9,912
Change in Accounts Payable
-4,1922,7903403,460234,412
Change in Other Net Operating Assets
-9,126897-7,2932,8575284,014
Operating Cash Flow
30,91056,75546,42845,43358,87528,108
Operating Cash Flow Growth
-47.45%22.24%2.19%-22.83%109.46%-21.27%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-17,068-23,326-27,504-16,403-11,323-14,660
Sale of Property, Plant & Equipment
1,1703095121,06482370
Cash Acquisitions
-3,372-3,152-53,096---326
Sale (Purchase) of Intangibles
-5,726-13,698-6,162-11,011-7,543-1,443
Investment in Securities
-6,440-27,16724,801-15,716-23,366-11,201
Other Investing Activities
2,7681,5213,3721,783777873
Investing Cash Flow
-28,663-65,513-58,077-40,283-41,373-26,387

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-20,25724,4905,493-3,520
Long-Term Debt Issued
---3,800--
Total Debt Issued
17,58220,25724,4909,293-3,520
Short-Term Debt Repaid
-----19,382-
Long-Term Debt Repaid
--1,264-1,294-4,947-1,015-785
Lease Payments
-1,415-1,263-1,294-1,147-1,015-785
Total Debt Repaid
-6,258-1,264-1,294-4,947-20,397-785
Net Debt Issued (Repaid)
11,32418,99323,1964,346-20,3972,735
Issuance of Common Stock
425397193805368334
Repurchase of Common Stock
---1,389---
Common Dividends Paid
-6,664-6,659-6,662-6,648-4,979-4,146
Other Financing Activities
-4,955-4,4413,573-2,266-1,853-1,345
Financing Cash Flow
1308,29018,911-3,763-26,861-2,422

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
9071,243224-59286733
Net Cash Flow
3,2847757,4861,328-9,07332

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
13,84233,42918,92429,03047,55213,448
Free Cash Flow Growth
-56.57%76.65%-34.81%-38.95%253.60%-48.20%
Free Cash Flow Margin
4.20%9.95%5.81%10.40%19.34%6.27%
Free Cash Flow Per Share
16.6140.1222.6934.8357.1616.17
Levered Free Cash Flow
-6,4361,62811,28512,23129,6771,031
Unlevered Free Cash Flow
-3,6213,96413,05313,30130,5691,629
Free Cash Flow After Leases
12,42732,16617,63027,88346,53712,663

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
4,4414,4413,4832,2661,8531,345
Cash Income Tax Paid
13,52613,52619,99320,04710,7147,437
Change in Working Capital
-22,863-11,636-29,989-20,182-7,855-18,498